Product How it works Pricing Blog FAQ About Contact
Ionis Pharmaceuticals

Ionis Pharmaceuticals (NASDAQ: IONS) revenue

Ionis Pharmaceuticals reported revenue of $943.7m for fiscal 2025, 33.8% more than in fiscal 2024 ($705.1m). Since fiscal 2016 its revenue has grown by 153.2%, an average growth of 10.9% a year.

Ionis Pharmaceuticals's best year of the last 10 was fiscal 2019. The biggest drop was in fiscal 2020, −35.0%.

Revenue, in millions of US dollars372.82016514.22017599.720181,1232019729.32020810.52021587.42022787.62023705.12024943.72025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$943.7m+33.8%−$381.7m−40.4%
2024$705.1m−10.5%−$475.1m−67.4%
2023$787.6m+34.1%−$353.7m−44.9%
2022$587.4m−27.5%−$410.2m−69.8%
2021$810.5m+11.1%−$30.2m−3.7%
2020$729.3m−35.0%−$172.1m−23.6%
2019$1,123m+87.2%$365.9m32.6%
2018$599.7m+16.6%−$61.4m−10.2%
2017$514.2m+37.9%$31.0m6.0%
2016$372.8m—−$20.2m−5.4%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Ionis Pharmaceuticals revenue compared with its sector

By revenue for its latest fiscal year, Ionis Pharmaceuticals ranks 154th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Ionis Pharmaceuticals, 33.8%.

RankCompanyRevenueRevenue growth
152ndMadrigal Pharmaceuticals$958.4m432.1%
153rdPennant Group$947.7m36.3%
154thIonis Pharmaceuticals$943.7m33.8%
155thTilray Brands$915.5m11.5%
156thInspire Medical Systems$912.0m13.6%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Ionis Pharmaceuticals

How much revenue did Ionis Pharmaceuticals make in fiscal 2025?
Ionis Pharmaceuticals reported revenue of $943.7m for fiscal 2025, compared with $705.1m in fiscal 2024.
How much has the revenue of Ionis Pharmaceuticals grown?
Between fiscal 2016 and fiscal 2025 it went from $372.8m to $943.7m: 153.2% more, an average growth of 10.9% a year.
What was the best year for revenue at Ionis Pharmaceuticals?
Of its last 10 fiscal years, fiscal 2019, with $1,123m.
Where does Ionis Pharmaceuticals rank in its sector by revenue?
It ranks 154th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Ionis Pharmaceuticals come from?
From the annual report (Form 10-K) that Ionis Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Ionis Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Ionis Pharmaceuticals: the Ionis Pharmaceuticals page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.